Cerus (CERS) Net Income towards Common Stockholders (2010 - 2026)

Cerus (CERS) reported Net Income towards Common Stockholders of -$1.6 million for Q1 2026, up 78.65% on a YoY basis from -$922488.0 in Q1 2025, and up 24.54% sequentially from -$2.2 million in Q4 2025.

Cerus (CERS) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Cerus (CERS) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 78.65% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$9.6 million (up 48.36% YoY), and the FY2025 full-year result was -$15.6 million, up 23.71% from the prior year.
  • Net Income towards Common Stockholders improved to -$1.6 million in Q1 2026, from -$2.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$20000.0 in Q3 2025 to a low of -$15.6 million in Q1 2023.
  • A 5-year average of -$7.0 million and a median of -$7.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders sank 664.08% in 2022 and soared 99.32% in 2025, its largest moves.
  • Tracing CERS's Net Income towards Common Stockholders over 5 years: stood at -$14.4 million in 2022, then jumped by 90.37% to -$1.4 million in 2023, then slumped by 51.48% to -$2.1 million in 2024, then retreated by 4.1% to -$2.2 million in 2025, then rose by 24.54% to -$1.6 million in 2026.
  • Business Quant data shows CERS's Net Income towards Common Stockholders at -$1.6 million in Q1 2026, -$2.2 million in Q4 2025, and -$20000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.08 Bn 175.79 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.71 Bn 125.83 Bn 3.81 Bn 745.00 Mn
3 Medtronic 108.79 Bn 99.57 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 68.41 Bn 66.96 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.34 Bn 44.67 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn 411.00 Mn
7 Dexcom 28.34 Bn 27.22 Bn 750.30 Mn 199.50 Mn
8 Smith & Nephew 26.87 Bn 26.29 Bn - -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn 176.78 Mn
10 Cerus 596.99 Mn 516.56 Mn 27.89 Mn -1.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.65 Mn
Dec 31, 2025 -2.18 Mn
Sep 30, 2025 -20,000.00
Jun 30, 2025 -5.72 Mn
Mar 31, 2025 -7.72 Mn
Dec 31, 2024 -2.10 Mn
Sep 30, 2024 -2.93 Mn
Jun 30, 2024 -5.78 Mn
Mar 31, 2024 -9.69 Mn
Dec 31, 2023 -1.39 Mn
Sep 30, 2023 -7.29 Mn
Jun 30, 2023 -13.33 Mn
Mar 31, 2023 -15.64 Mn
Dec 31, 2022 -14.38 Mn
Sep 30, 2022 -8.52 Mn
Jun 30, 2022 -8.40 Mn
Mar 31, 2022 -12.28 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 -12.44 Mn
Jun 30, 2021 -15.36 Mn